Efficacy and safety of apalutamide, abiraterone acetate, and bicalutamide in the treatment of metastatic hormone-sensitive prostate cancer
{{output}}
Objectives: To compare the efficacy and safety of three drugs-Apalutamide, Abiraterone, and Bicalutamide-combined with Androgen Deprivation Therapy (ADT) in patients with metastatic hormone-sensitive prostate cancer (mHSPC). ... ...
